MedPath
Found 407 clinical trials|View Analysis
Sort by:
Need a comprehensive medical report on "University of Cologne"?
Analyze the latest clinical research and treatment options
Summarize scientific findings from medical journals

EMMA-1 (Erbitux for Multiple Myeloma)

Phase 2
Terminated
Conditions
Multiple Myeloma
Interventions
First Posted Date
2006-08-24
Last Posted Date
2012-07-13
Lead Sponsor
Prof. Dr. Andreas Engert
Target Recruit Count
13
Registration Number
NCT00368121
Locations
🇩🇪

University of Cologne, Department I of Internal Medicine, Cologne, Germany

🇩🇪

Universtiy Hospital of Muenster, Internal Medicine A, Muenster, Germany

🇩🇪

University of Würzburg, Würzburg, Germany

Rituximab in Primary Lymphocyte Predominant Hodgkin´s Disease(RIPL)

Phase 2
Completed
Conditions
Lymphocyte Predominant Hodgkin´s Lymphoma (LPHD)
First Posted Date
2006-06-30
Last Posted Date
2008-08-12
Lead Sponsor
University of Cologne
Registration Number
NCT00346684
Locations
🇩🇪

University of Cologne, Cologne, Germany

A Study of the Glaukos Trabecular Micro-Bypass Stent in Refractory Open Angle Glaucoma Subjects

Phase 4
Completed
Conditions
Open-Angle Glaucoma
Interventions
Device: Glaucoma Surgery
First Posted Date
2006-05-16
Last Posted Date
2008-07-25
Lead Sponsor
Glaukos Corporation
Target Recruit Count
45
Registration Number
NCT00326040
Locations
🇳🇱

Ophthalmic Clinic, Rotterdam, Netherlands

🇩🇪

University of Cologne, Cologne, Germany

🇪🇸

Instituo Oftalmologico de Aragon, Zaragoza, Spain

and more 4 locations

Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients

Phase 2
Completed
Conditions
Lymphoma, Non-Hodgkin
Multiple Myeloma
Interventions
First Posted Date
2006-05-08
Last Posted Date
2014-03-13
Lead Sponsor
Genzyme, a Sanofi Company
Target Recruit Count
35
Registration Number
NCT00322842
Locations
🇩🇪

University of Cologne, Cologne, Germany

🇩🇪

Carl Gustav Carus University Hospital, Dresden, Germany

🇩🇪

University of Heidelberg, Heidelberg, Germany

LDL Receptor Under Ezetimibe and Simvastatin

Phase 4
Completed
Conditions
Healthy Men
First Posted Date
2006-04-25
Last Posted Date
2014-12-03
Lead Sponsor
University of Cologne
Target Recruit Count
60
Registration Number
NCT00317993
Locations
🇩🇪

Medizinische Klinik II und Poliklinik für Innere Medizin, Cologne, Germany

Effects of Pregabalin on Mechanical Hyperalgesia

Phase 4
Conditions
Tactile Hyperalgesia
Neuropathic Pain
First Posted Date
2006-04-04
Last Posted Date
2007-04-05
Lead Sponsor
Professional Associations Clinic Bergmannsheil
Target Recruit Count
120
Registration Number
NCT00310583
Locations
🇩🇪

Dept. of Anaesthesia and Transfusion Medicine, University of Tuebingen, Tuebingen, Germany

🇩🇪

Health Care Centre, Dept. of Neurology, Johannes Gutenberg University of Mainz, Mainz, Germany

🇩🇪

Interdisciplinary Dept. of Pain Management, Dept. of Anaesthesiology, Ludwig-Maximilians-University, Munich, Germany

and more 14 locations

Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer

Not Applicable
Conditions
Breast Cancer
First Posted Date
2006-04-03
Last Posted Date
2009-02-09
Lead Sponsor
Heinrich-Heine University, Duesseldorf
Target Recruit Count
1234
Registration Number
NCT00309920
Locations
🇩🇪

Knappschaft Krankenhaus, Bochum-Langendreer, Germany

🇩🇪

Praxis Fuer Haematologie Internistische Onkologie, Cologne, Germany

🇩🇪

St. Elisabeth-Krankenhaus - Koeln, Cologne, Germany

and more 44 locations

Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)

Phase 2
Completed
Conditions
Chronic Lymphocytic Leukemia
First Posted Date
2006-04-03
Last Posted Date
2016-10-03
Lead Sponsor
German CLL Study Group
Target Recruit Count
75
Registration Number
NCT00309881
Locations
🇩🇪

Kreiskrankenhaus, Bad Hersfeld, Germany

🇩🇪

Internistische Onkologische Praxis - Kronach, Kronach, Germany

🇩🇪

Universitaetsklinikum Essen, Essen, Germany

and more 15 locations

A Clinical Trial on the Antipsychotic Properties of Cannabidiol

Phase 2
Completed
Conditions
Schizophrenia
Psychotic Disorders
Interventions
Drug: Cannabidiol/Placebo
Drug: Placebo/Cannabidiol
First Posted Date
2006-03-31
Last Posted Date
2008-07-25
Lead Sponsor
University of Cologne
Target Recruit Count
29
Registration Number
NCT00309413
Locations
🇩🇪

University of Cologne, Dept. of Psychiatry and Psychotherapy, Cologne, NRW, Germany

Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma

Phase 2
Completed
Conditions
Lymphoma
Interventions
Biological: pegfilgrastim
Biological: rituximab
Other: pharmacological study
Radiation: radiation therapy
First Posted Date
2006-02-13
Last Posted Date
2021-05-18
Lead Sponsor
German High-Grade Non-Hodgkin's Lymphoma Study Group
Target Recruit Count
586
Registration Number
NCT00290667
Locations
🇨🇿

University Hospital Brno, Brno, Czechia

🇫🇷

Hopital Debrousse, Lyon, France

🇨🇿

Charles University Hospital, Prague 5, Czechia

and more 328 locations
© Copyright 2025. All Rights Reserved by MedPath